Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis.


Journal

Journal of neuroimmunology
ISSN: 1872-8421
Titre abrégé: J Neuroimmunol
Pays: Netherlands
ID NLM: 8109498

Informations de publication

Date de publication:
15 04 2019
Historique:
received: 18 03 2018
revised: 30 09 2018
accepted: 05 10 2018
pubmed: 27 10 2018
medline: 4 12 2019
entrez: 27 10 2018
Statut: ppublish

Résumé

Cigarette smoking is the most prominent significant cause of death and morbidity. It is recognised as a risk factor for a number of immune mediated, inflammatory diseases including multiple sclerosis (MS). Here, we review the complex immunological effects of smoking on the immune system, which include enhancement of inflammatory responses with a parallel reduction of some immune defences, resulting in an increased susceptibility to infection and a persistent proinflammatory environment. We discuss the effect of smoking on the susceptibility, clinical course, disability, and mortality in MS, the likely benefits of smoking cessation, and the specific immunological effects of smoking in MS. In conclusion, smoking is an important environmental risk factor for MS occurrence and outcome, and it acts in significant part through immunological mechanisms.

Identifiants

pubmed: 30361070
pii: S0165-5728(18)30130-9
doi: 10.1016/j.jneuroim.2018.10.004
pii:
doi:

Substances chimiques

Inflammation Mediators 0
Tobacco Smoke Pollution 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-34

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Mohammed Alrouji (M)

Division of Clinical Neuroscience, Section of Clinical Neurology, University of Nottingham, Nottingham, United Kingdom; School of Applied Medical Sciences, Shaqra University, Saudi Arabia.

Ali Manouchehrinia (A)

Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.

Bruno Gran (B)

Division of Clinical Neuroscience, Section of Clinical Neurology, University of Nottingham, Nottingham, United Kingdom.

Cris S Constantinescu (CS)

Division of Clinical Neuroscience, Section of Clinical Neurology, University of Nottingham, Nottingham, United Kingdom. Electronic address: cris.constantinescu@nottingham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH